Leon M Ptaszek, Fidencio Saldana, Igor F Palacios, Sean M Wu
{"title":"Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review.","authors":"Leon M Ptaszek, Fidencio Saldana, Igor F Palacios, Sean M Wu","doi":"10.4137/cmc.s2326","DOIUrl":null,"url":null,"abstract":"<p><p>We describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. In both cases, the patients were asymptomatic prior to developing additional cardiopulmonary issues that apparently enhanced right-to-left intracardiac shunting. The patients were both treated with percutaneously deployed occlusion devices, with excellent results. Symptoms and positional oxygen desaturation resolved after device placement in both cases. In addition, these patients remain symptom-free 30 months after device implantation.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"37-43"},"PeriodicalIF":0.0000,"publicationDate":"2009-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s2326","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical medicine. Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/cmc.s2326","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
Abstract
We describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. In both cases, the patients were asymptomatic prior to developing additional cardiopulmonary issues that apparently enhanced right-to-left intracardiac shunting. The patients were both treated with percutaneously deployed occlusion devices, with excellent results. Symptoms and positional oxygen desaturation resolved after device placement in both cases. In addition, these patients remain symptom-free 30 months after device implantation.